New Brain Cell Revelation Offers Hope for Multiple Sclerosis Treatment

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to teh persistent inflammation characteristic of the disease.

The discovery, reported in Neuron, is a meaningful step towards understanding the complex mechanisms that drive the disease adn provides a promising new avenue for research into more effective therapies for this debilitating condition.

MS is a chronic disease in which the immune system mistakenly attacks the brain and spinal cord, disrupting dialog between the brain and the body. While many individuals initially experience relapses and remissions, a significant proportion transition to progressive MS, a phase marked by a steady decline in neurological function with limited treatment options.

To model what happens in the disease, researchers at the University of Cambridge, UK, and National Institute on Aging, US, took skin cells from patients with progressive MS and reprogrammed them into induced neural stem cells (iNSCs), an immature type of cell capable of dividing and differentiating into various types of brain cells.

Using this ‘disease in a dish’ approach,the team observed that a subset of the cultured brain cells was reverting to an earlier developmental stage,transforming into an unusual cell type known as radial glia-like (RG-like) cells. Notably,these cells were highly specific and appeared approximately six times more frequently in iNSC lines derived from individuals with progressive MS compared to controls.As an inevitable result, they were designated as disease-associated RG-like cells (DARGs).

these DARGs exhibit characteristic features of radial glia – specialized cells that serve as scaffolding during brain progress and possess the capacity to differentiate into other brain cells. They also showed signs of heightened inflammatory activity.

“These DARGs appear to be stuck in a developmental holding pattern,” explains Dr. Valentina Lorenzini, lead author of the study from the University of Cambridge. “Rather of maturing into functional brain cells, they remain in this immature state and seem to be actively contributing to the inflammatory environment within the central nervous system.”

Further investigation revealed that DARGs express several genes associated with inflammation and immune response. The researchers believe these cells may be actively involved in perpetuating the chronic inflammation that drives the progression of MS.

“This is a really exciting finding because it suggests a new therapeutic target,” says Dr. Lorensini. “If we can find a way to either eliminate these DARGs or encourage them to mature into functional brain cells, we might be able to slow down or even halt the progression of MS.”

The team is now working to understand the precise mechanisms that cause the formation of DARGs and to identify potential drugs that could target these cells. They are also exploring whether similar cells are present in the brains of individuals with progressive MS.

Key Takeaways

• Researchers discovered a new brain cell type, disease-associated RG-like cells (DARGs), prevalent in progressive MS patients.
• DARGs appear to be stuck in an immature developmental stage and contribute to inflammation.
• Targeting DARGs could offer a new therapeutic strategy for progressive MS.